Issue 2, 2025, Issue in Progress

Monophthalates of betulinic acid and related pentacyclic triterpenes inhibit efficiently the SOS-mediated nucleotide exchange and impact PI3K/AKT signaling in oncogenic K-RAS4B proteins

Abstract

Betulinic acid and other herbal pentacyclic triterpenes have attracted interest in cancer research as these natural products induce apoptosis and suppress tumor progression. However, the molecular basis of the antitumor effect is still unknown. Here we show that monophthalates of betulinic acid and related triterpenes inhibit GDP/GTP exchange in oncogenic K-RAS4B proteins via the PI3K/AKT downstream cascade. According to a binding model based on molecular modelling, these derivatives act like a molecular glue that stabilizes an unproductive K-RAS4Ballo:SOS complex. This represents a new mode of action and could be an attractive route for targeting RAS-related cancers.

Graphical abstract: Monophthalates of betulinic acid and related pentacyclic triterpenes inhibit efficiently the SOS-mediated nucleotide exchange and impact PI3K/AKT signaling in oncogenic K-RAS4B proteins

Supplementary files

Article information

Article type
Paper
Submitted
02 Dec 2024
Accepted
02 Jan 2025
First published
10 Jan 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 883-895

Monophthalates of betulinic acid and related pentacyclic triterpenes inhibit efficiently the SOS-mediated nucleotide exchange and impact PI3K/AKT signaling in oncogenic K-RAS4B proteins

G. E. Benary, F. Kilgenstein, S. Koller and J. Scherkenbeck, RSC Adv., 2025, 15, 883 DOI: 10.1039/D4RA08503E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements